About
Real Imaging develops technology for detecting breast cancer. The companys MIRA solution utilizes dual-head proprietary structured-light projection infrared imaging technology to construct 3D vascular maps of the breasts. The MIRA technology can assess breast vascularity for the likelihood of malignancy. The assessment is based on multidisciplinary machine learning technology that provides the physician with a risk assessment score that has been clinically validated in a population of women with histology-confirmed breast cancer. Real Imagings Real Imager 8 provides a touch-free, radiation-free procedure to determine the likelihood of breast cancer through a noninvasive imaging procedure. Unlike mammography, the Real Imager 8 does not involve potentially painful compression of the breast. In May 2014, Real Imaging received CE mark approval for its Real Imager 8 breast cancer screening system.